Impact of Aging on Stem Cell Repair in Atherosclerosis

衰老对动脉粥样硬化干细胞修复的影响

• 批准号: 6948334
• 负责人: Pascal J. Goldschmidt-Clermont
• 金额: $ 6.09万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-08-15 至 2009-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6948334
• 关键词: Impact; Aging; Stem; Cell; Repair

DESCRIPTION (provided by applicant): Atherosclerosis represents an aberrant, continuous reparative inflammatory process in response to repeated injuries to the vessel wall. Indeed, the cardiovascular system is continuously exposed to a multitude of insults whose impact cumulates with the passage of time. Two sources of cells participating in the repair process exist: (1) local, differentiated, vascular endothelial and smooth muscle cells that migrate from adjacent vessel segments; and (2) recruited stem cells/vascular progenitor cells from the bone marrow, via peripheral circulation. We have recently discovered that chronic administration of whole bone marrow (BM) cells significantly reduced atherosclerotic lesion formation in an established mouse model of atherosclerosis--ApoE / C57/B6 mice fed high fat/cholesterol, Western-type diet--even in the absence of restoration of ApoE gene expression and normalization of plasma cholesterol levels (>1200 mg/dl). Furthermore, BM cells from young, but not old, ApoE-/- mice were capable of vascular rejuvenation and atherosclerosis prevention. These data underscore the importance of stem cells/vascular progenitor cells in vascular healing and atherogenesis and provide support for the use of stem/progenitor cell therapy as a novel preventative and/or treatment strategy for atherosclerosis, particularly for individuals whose bone marrow, and its obsolescence, represents the bottleneck for long-term integrity of the cardiovascular system. In this project, we propose to test the hypothesis that after a lifetime of repairing atherosclerotic arteries, the supply of the specific type(s) of vascular progenitor cells (VPCs) needed to maintain the homeostasis of the cardiovascular system is somehow exhausted or functionally impaired. If the VPC "spare parts" can be outsourced, the repair process can be boosted at appropriate intervals and atherosclerotic consequences delayed, perhaps indefinitely. Specific Aim 1: To determine the quantitative composition (FACS analysis), progeny functional characteristics, and gene expression phenotype (microarray analysis) of whole bone marrow cells or lineage negative side population (lin-SP) cells obtained from young versus old (wild-type, ApoE / and LDLR -/-) mice; Specific Aim 2: To establish that competent VPCs are encompassed in the linSP fraction in the marrow, which convey the anti-atherosclerotic efficacy, by testing the effects of unfractionated bone marrow cells, enriched lin-SP cells and bone marrow cells deprived of lin-SP fraction obtained from young versus old (wild-type and ApoE -/) mice in suppressing elevated plasma levels of chemo-cytokines and growth factors and in preventing atherosclerotic lesion formation in ApoE 4 mice; and Specific Aim 3: To determine the efficacy of unfractionated bone marrow cells, lin-SP cells and bone marrow cells minus lin-SP fraction obtained from young versus old (wild-type and LDLR 4-) mice in suppressing elevated plasma levels of chemo-cytokines and growth factors and in the prevention of atherosclerosis in LDLR t- mice--a trait resembling familial hypercholesterolemia. We will determine whether circulatory inflammatory factors, including IL-6, M-CSF, TNFc_, VEGF and metalloproteinase-9, serve as signals to mobilize and recruit vascular progenitor cells in response to vascular injury. Results from these studies will provide insight into BM stern cell biology in relation to atherosclerosis, and reveal new markers that could be used to isolate and even enrich vascular progenitor cells in the BM, especially old BM. The findings will also help determine the optimal vascular progenitor cell phenotypes for the treatment of atherosclerosis.

描述（由申请方提供）：动脉粥样硬化是一种异常的、持续的修复性炎症过程，对血管壁的反复损伤做出反应。事实上，心血管系统持续暴露于大量的损伤，其影响随着时间的推移而累积。参与修复过程的细胞有两种来源：（1）从相邻血管节段迁移的局部分化的血管内皮细胞和平滑肌细胞;和（2）通过外周循环从骨髓募集的干细胞/血管祖细胞。我们最近发现，在已建立的动脉粥样硬化小鼠模型中，即使在没有ApoE基因表达恢复和血浆胆固醇水平正常化（> 1200 mg/dl）的情况下，长期给予全骨髓（BM）细胞也显著减少了动脉粥样硬化病变的形成--ApoE/C57/B6小鼠喂食高脂肪/胆固醇、西式饮食。此外，来自年轻而非老年ApoE-/-小鼠的BM细胞能够血管再生和预防动脉粥样硬化。这些数据强调了干细胞/血管祖细胞在血管愈合和动脉粥样硬化形成中的重要性，并为使用干细胞/祖细胞疗法作为动脉粥样硬化的新型预防和/或治疗策略提供了支持，特别是对于骨髓及其老化代表心血管系统长期完整性瓶颈的个体。在这个项目中，我们提出了一个假设，即经过一辈子的动脉粥样硬化修复，维持心血管系统稳态所需的特定类型的血管祖细胞（VPC）的供应在某种程度上耗尽或功能受损。如果VPC的“备件”可以外包，修复过程可以在适当的时间间隔和动脉粥样硬化的后果推迟，也许是无限期的。具体目标1：确定定量成分（FACS分析）、后代功能特征和基因表达表型（微阵列分析）从年轻人与老年人获得的全骨髓细胞或谱系阴性侧群（lin-SP）细胞（野生型、ApoE/和LDLR-/-）小鼠;特异性目标2：为了确定骨髓中的linSP组分中包含有能力的VPC，其传递抗动脉粥样硬化功效，通过测试未分级骨髓细胞的作用，从年轻人与老年人中获得的富集lin-SP细胞和去除lin-SP部分的骨髓细胞（野生型和ApoE-/）小鼠中抑制升高的化学细胞因子和生长因子的血浆水平以及预防ApoE 4小鼠中动脉粥样硬化病变形成的作用;以及为了确定未分级骨髓细胞的功效，从年轻人与老年人中获得的lin-SP细胞和骨髓细胞减去lin-SP部分（野生型和LDLR 4-）小鼠在抑制升高的化学细胞因子和生长因子的血浆水平以及在LDLR t-小鼠中预防动脉粥样硬化（一种类似家族性高胆固醇血症的性状）方面的作用。我们将确定循环炎症因子，包括IL-6，M-CSF，TNFc_2，VEGF和金属蛋白酶-9，是否作为信号动员和招募血管祖细胞，以响应血管损伤。这些研究的结果将提供关于动脉粥样硬化的BM干细胞生物学的见解，并揭示可用于分离甚至富集BM中的血管祖细胞的新标记物，特别是旧BM。这些发现也将有助于确定治疗动脉粥样硬化的最佳血管祖细胞表型。